FDA Approves Ankle-Replacement System
The U.S. Food and Drug Administration has approved the Scandinavian Total Ankle Replacement (S.T.A.R.) System for patients with arthritic or deformed ankles.
Month: May 2009
Burrill Report: Financing Activity May Lift Cloud Hanging Over Biotech Industry
While biotech leaders from all over the world gathered at the 2009 BIO International Convention in Atlanta, financing activity in the sector raised hope that the cloud hanging over the industry may be lifting a little.
SyntheMed’s REPEL-CV Approved by Australian Regulators
REPEL-CV, an anti-adhesion barrier developed by biomaterials company SyntheMed, has received approval by the Australian Therapeutic Goods Administration for use in open-heart surgery.
Explore Investment and Networking Opportunities at IN3 East
Hundreds of companies such as Bain Capital Ventures, Becton Dickinson, Covidien, DePuy Mitek Worldwide, Kimberly-Clark, Medtronic, Novartis BioVenture Fund, Quaker BioVentures, Siemens Venture Capital, Stryker […]
Sonitus Medical Attracts CIA Dollars
Sonitus Medical Inc., developer of a non-surgical hearing aid that is designed to transmit sound via the teeth, announced that it has received an investment from In-Q-Tel, a strategic investment firm that was started by the CIA.
Biogen Idec, Electro-Optical Among “5 Stocks Approaching Greatness”
Investment website The Motley Fool has published a list of five stocks approaching greatness–and four of them are within the life sciences industry.
Clarient Stock Deal Frees Up Cash for Safeguard Scientifics
Safeguard Scientifics Inc. has received $19.5 million in cash, and freed up another $12.3 million in cash due to one of its portfolio companies completing the second part of a private placement of convertible preferred stock.
Compounds in Plant DNA May Help Humans
That little houseplant sitting on your windowsill could one day save your life.
TargetScan Touch Proven Effective in Duke Study
A study published in Technology in Cancer Research and Treatment shows that Envisioneering Medical’s TargetScan Touch system is more effective in detecting prostate cancer than traditional biopsy methods.
TearLab Gets FDA 510(k) Approval
TearLab Corporation has received FDA 510(k) clearance of its TearLab Osmolarity System.